Delivery Order SPE2DB20D3303-SPE2DB24FZ4M8
Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, valued at $2,537.05. The contract is for the supply of 4,563,982,171 units of Insulin Glargine-yfgn U100 Pen, a specialty pharmaceutical product, with a period of performance through March 18, 2024. This delivery order is placed under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA,...
- The U.S. Department of Defense (DoD) has awarded a firm fixed price delivery order contract (SPE2DX15D2101|SPE2DX24F50XW) worth $1,647.60 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the supply of INSULIN GLARGINE-YFGN U100 PEN 3ML, a specialty pharmaceutical product. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with a potential value of up to $999,999,999.00 from the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide insulin glargine-yfgn U100 pens. The contract has a ceiling value of $1,872.71 and a performance period through March 29, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564029748 - Insulin Glargine-YFGN U100 Pen 3 ML. The contract, valued at $6,590.40, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of insulin glargine-yfgn U100 pens, a specialty pharmaceutical product, to support military treatment programs and facilities. The contract has a ceiling value of $7,884.18 and a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,957,775 units of insulin glargine-yfgn U100 pen 3ml. The $1,977.12 contract has a performance period through March 14, 2024. This award is associated with a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 held by AmerisourceBergen Drug Corp as the prime contractor, which serves as the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of pharmaceutical products. The delivery order, valued at $1,784.90, is for insulin glargine-yfgn U100 pens. This order is placed under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31,...
- This federal contract award, with ID SPE2DX15D3005|SPE2DX24F3QHD, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,977.12 firm fixed price delivery order is for the supply of Insulin Glargine-yfgn U100 Pen 3ML, a pharmaceutical product. This award is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31,...
- This is a delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of insulin glargine-yfgn U100 pens. The $5,011.16 firm fixed-price contract has an ultimate completion date of August 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other agencies to provide a wide range of medical commodities, including critical care products and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Insulin Glargine-YFGN U100 Pen 3ML pharmaceutical product with a ceiling value of $1,207.64. This is a firm fixed price delivery order with an ultimate completion date of January 2, 2026, with no set-aside designation applied. The award was competitively bid and represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical supplier to the...